3Masetti P,Murphy SF,Kouchoukos NT.Vasopress in therapy for vasopIegic syndrome foIIowing cardiopuImonary bypass[J].J Card Surg,2002,17(6):485-489.
44 Levin RL Degrange MA,Bruno GF,et aI.MethyIene bIue reduces mortaIity and morbidity in vasopIegic patients after cardiac surgery[J].Ann Thorac Surg,2004,77(2):496-499.
二级参考文献14
1Dunser MW, Wenzel V, Mayr AJ, et al. Management of vasodilatory shock: defining the role of arginine vasopressin [J].Drugs,2003,63(3):237
2Taylor K. SIRS: the systemic inflammatory response syndrome after cardiac operations[J].Ann Thorac Surg, 1996,61: 1607
3Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery[J].Ann Thorac Surg, 2004 ,77(2):496
4Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open heart surgery[J].J Cardiovasc Surg (Torino),1998,39(5):619
5Tuman KJ, McCarthy RJ, O'Connor CJ, et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass[J].Anesth Analg,1995,80(3):473
6Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass[J].Ann Thorac Surg,1998,66(5 Suppl): S12
7Verrier ED, Morgan EN. Endothelial response to cardiopulmonary bypass surgery[J].Ann Thorac Surg,1998, 66(5 Suppl): S17
8Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent[J].J Thorac Cardiovasc Surg, 1998, 116(6): 973
9Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome: a new dilemma[J].J Thorac Cardiovasc Surg, 1994,107(3): 942
10Speziale G, Ruvolo G, Marino B. A role for nitric oxide in the vasoplegic syndrome[J].J Cardiovasc Surg,1996 ,37(3):301
